Azurion 3 M12 System Code: (1) 722063 (2) 722221
Published February 12, 2025 · Recall initiated: January 13, 2025
Summary
FDA records medical device Class II recall Z-1087-2025, published February 12, 2025 and initiated January 13, 2025. Recalling firm: PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.; Status: Ongoing; Reported quantity: 9 units US; 101 units OUS; Lot: UDI: (1) 722063 00884838085275(21) (2) 722221 00884838099203(21). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Potential safety issue with the AD7 and AD7X patient tables (both tilt and non-tilt versions) part of the Philips Allura and Azurion systems. During manual repositioning of the patient tabletop, a finger can get entrapped between the longitudinal guiding rails and the tabletop. This may result in an injury of the finger, applicable for operators and service personnel
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
- Distributor
- Worldwide distribution - US Nationwide and the countries of Canada, Afghanistan, Albania, Algeria, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahrain, Bangladesh, Belarus, Belgium, Bolivia, Bosnia and Herzegovina, Brazil, Brunei Darussalam, Bulgaria, Cambodia, Cayman Islands, Chile, China, Colombia, Costa Rica, C®te D'Ivoire, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Ethiopia, Fiji, Finland, France, French Polynesia, Georgia, Germany, Ghana, Gibraltar, Greece, Guadeloupe, Guatemala, Guinea, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, JAMAICA, Japan, Jordan, Kazakhstan, Kenya, Korea, Republic of Kosovo, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Latvia, Lebanon, Libya, Lithuania, Macao, Macedonia, Malaysia, Maldives, Malta, Martinique, Mauritania, Mauritius, Mexico, Moldova, Mongolia, Morocco, Myanmar, Nepal, Netherlands, New Caledonia, New Zealand, Nicaragua, Nigeria, Norway, Oman, Pakistan, Palestine, State of Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, R®union, Romania, Russian Federation, Saudi Arabia, Senegal Serbia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sri Lanka, Sudan, Sweden, Switzerland, Syrian Arab Republic, Taiwan, Tanzania, Thailand, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Ukraine, United Arab Emirates, United Kingdom, Uruguay, Uzbekistan, Venezuela, Viet Nam, Yemen.
- Lot
- UDI: (1) 722063 00884838085275(21) (2) 722221 00884838099203(21)
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- Netherlands
Related recalls
- FDAPhilips Azurion 5 M12. Model Number: 722227.November 4, 2026
- FDAPhilips Azurion 3 M12. Model Numbers: 722063, 722221.November 4, 2026
- FDAPhilips Azurion 7 M20. Model Numbers: 722079, 722224, 722282.November 4, 2026
- FDAPhilips Azurion 5 M20. Model Numbers: 722228, 722281.November 4, 2026
- FDASenTiva, REF: 1000C, Generators Part of the VNS Therapy System with Microburst Stimulation. Used for VagusFebruary 12, 2025
- FDAThe Rapid fFN Specimen Collection Tube (PN: 71550-001) is a component of the Rapid fFN Specimen Collection kitFebruary 12, 2025
Questions about this recall
Was Azurion 3 M12 System Code: (1) 722063 (2) 722221 recalled?
Yes. FDA published recall Z-1087-2025 on February 12, 2025. Reported hazard: Potential safety issue with the AD7 and AD7X patient tables (both tilt and non-tilt versions) part of the Philips Allura and Azurion systems. During manual repositioning of the patient tabletop, a finger can get entrapped between the longitudinal guiding rails and the tabletop. This may result in an injury of the finger, applicable for operators and service personnel
What should I do if I have this product?
Voluntary: Firm initiated · Letter